TABLE 2.
Antibiotic agenta | MICb (μg/ml) | Distance between MIC lines in combination therapy vs. single therapy (mm) |
---|---|---|
Single agent | ||
FOF | 3 | |
VAN | 3 | |
DAP | 3 | |
LZD | 2 | |
2nd agent | ||
IPM/CS+FOF | 0.38 | 8 |
IPM/CS+VAN | 1.5 | 3 |
FOF+VAN | 2 | 2 |
IPM+DAP | 1.5 | 3 |
FOF+DAP | 1.5 | 3 |
IPM+LZD | 0.75 | 4 |
FOF+LZD | 1 | 3 |
3rd agent | ||
IPM+FOF+VAN | 0.75 | 6 |
IPM+FOF+DAP | 0.75 | 6 |
IPM+FOF+LZD | 0.38 | 7 |
IPM/CS, imipenem/cilastatin; FOF, fosfomycin; VAN, vancomycin; DAP, daptomycin; LZD, linezolid.
Determined by Etest.